AbbVie Inc.
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- ABBV [1]
- Listing exchanges
- NYSE [1]
- SEC industry
- Pharmaceutical Preparations [1]
- Business sectors
- pharmaceutical industry; biotechnology [2]
- Company / filing name
- AbbVie Inc. [1]
- Headquarters location
- North Chicago [2]
- Business address
- 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064 [1]
- Founded
- 2012-04-10 [2]
- Legal form
- Delaware corporation [2]
- Incorporation jurisdiction
- Delaware, United States [1]
- Leadership in background record
- Robert A. Michael [2]
- Official website
- www.abbvie.com ↗ [2]
- Annual revenue
- USD 61,160,000,000 · 2025-01-01 to 2025-12-31 [3]
- Total assets
- USD 133,960,000,000 · at 2025-12-31 [3]
- Net income / loss
- USD 4,226,000,000 · 2025-01-01 to 2025-12-31 [3]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- US00287Y1091 [2]
- CIK
- 0001551152 [1]
- SIC code
- 2834 [1]
- Country in background record
- United States [2]
Company positioning and business
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. [4]
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. [4]
Background text: Wikipedia contributors, AbbVie. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Management and corporate governance
The Wikidata background record identifies Robert A. Michael in the chief-executive role. This background entry is not an official confirmation of the current board or executive roster. [2]
Understanding company scale
Revenue: USD 61,160,000,000, 2025-01-01 to 2025-12-31. Reported in Form 10-K filed 2026-02-20. Figures are consolidated XBRL facts; reporting periods and amendments must be checked before comparing companies. [3]
Net income / loss: USD 4,226,000,000, 2025-01-01 to 2025-12-31. Reported in Form 10-K filed 2026-02-20. Figures are consolidated XBRL facts; reporting periods and amendments must be checked before comparing companies. [3]
Total assets: USD 133,960,000,000, at 2025-12-31. Reported in Form 10-K filed 2026-02-20. Figures are consolidated XBRL facts; reporting periods and amendments must be checked before comparing companies. [3]
Financial year, securities and disclosures
The SEC submissions record gives AbbVie Inc. a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: ABBV (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [5]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 2834. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was AbbVie Inc. founded?
Founded: 2012-04-10. The linked source provides the background record. [2]
Where is the headquarters of AbbVie Inc.?
Headquarters location: North Chicago. The linked source provides the background record. [2]
Which business sectors are recorded for AbbVie Inc.?
Business sectors: pharmaceutical industry; biotechnology. The linked source provides the background record. [2]
AbbVie Inc. relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — AbbVie Inc. filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- SEC — AbbVie Inc. reported financial facts ↗
- Wikipedia contributors — AbbVie (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.